SPSiddhi Pawar

Siddhi Pawar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Siddhi Pawar has a total of 24 co-authors. Here are the top co-authors by number of shared publications:

  • Chaoyang Xue

    Public Health Research Institute, New Jersey Medical School, Rutgers University

    4 shared publications
  • Amariliz Rivera

    Center for Immunity and Inflammation, and Department of Pediatrics, New Jersey Medical School, Rutgers University, Newark, NJ, 07103, United States

    3 shared publications
  • Samantha L. Avina

    Rutgers University, USA

    3 shared publications
  • Chaoyang Xue

    Public Health Research Institute, Rutgers School of Graduate Studies, Newark, New Jersey, USA

    2 shared publications
  • Yina Wang

    Public Health Research Institute, and Department of Microbiology, Biochemistry and Molecular Genetics, New Jersey Medical School, Rutgers University, Newark, NJ, 07103, United States

    2 shared publications
  • Yu Zhang

    Public Health Research Institute, and Department of Microbiology, Biochemistry and Molecular Genetics, New Jersey Medical School, Rutgers University, Newark, NJ, 07103, United States

    2 shared publications

Latest Publications

  • Open Access

    A SuperSelective primer-based real-time PCR platform for hypersensitive detection of azole resistance in Cryptococcus neoformans

    by Siddhi Pawar, Honglin H. Xue, Sophia Wang, Salvatore A. E. Marras, Chaoyang Xue

    Cryptococcus neoformans is the leading cause of fungal meningitis with limited treatment options, making early and accurate diagnosis critical for improved patient outcomes. Current diagnostic methods for cryptococcosis rely largely on capsule antigen detection and fungal culture, which are time-consuming and unable to identify mutation-driven antifungal resistance. In this study, we have developed a SuperSelective primer-based PCR (SSP-PCR) platform for the rapid and specific detection of azole resistance-associated single-nucleotide polymorphisms (SNPs). We demonstrate that SSP-PCR reliably detected a single copy of mutant allele in the presence of excess wild-type (WT) DNA, with sensitivity reaching a 1:10 4 mutant-to-WT ratio. Incorporating molecular beacon (MB) probes into our SSP-PCR platform further enhanced amplification specificity, enabling selective detection of the ERG11 Y145F (A434T) mutation, which is known to confer high azole resistance. Using genomic DNA from in vitro cultures and mouse lung tissues infected with either WT strain H99 or a fluconazole-hyper-resistant mrl1 clinical isolate that carries the ERG11 (A434T) mutation, or both strains, we successfully detected the A434T mutant allele in both settings. Moreover, our SSP-PCR simultaneously identified ERG11 (A434T) and the multi-azole resistance-associated ERG11 (G1885A) mutant alleles in a single-tube duplex reaction. Collectively, this is the first study that utilizes the SSP-PCR platform to provide a robust and ultrasensitive molecular approach for the detection of azole resistance in C. neoformans, which provides a proof-of-concept methodology for its potential high-throughput clinical screening applications. IMPORTANCE: Invasive fungal infections are a growing public health threat causing over 1.5 million deaths annually, with cryptococcal meningitis accounting for over 15% of HIV/AIDS-related mortality. The problem is aggravated by limited treatment options and emerging drug resistance. Long-term use of fungistatic azoles like fluconazole promotes the emergence of azole resistance and heteroresistance, contributing to clinical treatment failure. Current diagnostic assays often fail to detect resistance-associated mutations within heterogeneous fungal populations, limiting their clinical utility. In this study, we developed a SuperSelective primer-based PCR (SSP-PCR) platform for the rapid and ultrasensitive detection of azole resistance-associated single-nucleotide polymorphisms (SNPs) in Cryptococcus neoformans . By integrating molecular beacon probes, this assay achieves high specificity and enables the detection of multiple SNP mutations in a single reaction. Our SSP-PCR platform offers a powerful molecular approach for identifying azole resistance with the potential to improve diagnostic precision and guide antifungal therapy in clinical settings.

  • Open Access

    Development of an HK-fbp1-based vaccine platform against Cryptococcus neoformans

    by Yu Zhang, Yina Wang, Keyi Wang, Lu Gan, Aaron Lemmer, Siddhi Pawar, Amariliz Rivera, Chaoyang Xue

    Cryptococcal meningitis remains a leading cause of death among HIV/AIDS patients, and no antifungal vaccine is available in clinical use. We previously showed that mice immunized with a heat-killed preparation of Cryptococcus neoformans ( Cn ) fbp1 Δ mutant (HK-fbp1) are protected against cryptococcosis and other invasive mycoses, suggesting that HK-fbp1 is an intriguing vaccine candidate for further study. Recent studies have reported that heat-killed wild type H99 (HK-H99) can also offer some protection in other vaccination models. Here we set out to decipher the differential protective capacity of HK-fbp1 versus HK-H99 across multiple conditions. We observed that HK-fbp1 confers superior protection in both prophylactic and therapeutic intranasal immunization settings than HK-H99, which was associated with greater activation of pulmonary CD4⁺ T cells and stronger airway IFN- γ production. In addition, HK-fbp1 preparations were highly stable, retaining full protective efficacy even after 5 years of frozen storage. Mice intranasally immunized with two-dose HK-fbp1 were protected against challenge by up to 10⁶ H99 cells, a 100-fold increase over the commonly used lethal inoculum. Addition of a CpG adjuvant ODN to HK-fbp1 (HK-bp1/ODN) led to a 5-fold reduction of the intranasal vaccine inoculum required for protection, and itssingle-dose intramuscular vaccination induced protection persisted for at least 3 months post vaccination. Together, these findings highlight the robust protective capacity and formulation versatility of HK-fbp1, supporting its further development as a stable, dose-sparing antifungal vaccine candidate. Importance: Vaccines against viral and bacterial infections have had a transformative impact in our fight against infectious diseases. However, there are no fungal vaccines currently approved for clinical use. This study provides a full characterization of a potent whole cell fungal vaccine we recently developed based on heat-killed Cryptococcus neoformans fbp1 Δ mutant (HK-fbp1) and its adjuvanted version. Our data demonstrates that HK-fbp1 and its adjuvanted version have superior protection advantage than heat-killed wild type H99. Importantly, the HK-fbp1 is highly stable with its preparation remained protective potency after years of frozen storage. Including a CpG adjuvant ODN further reduced the antigen requirement in the intranasal route, and provided HK-fbp1 a highly durable protection after single intramuscular vaccination. These clinically relevant attributes of a successful vaccine, including high stability, dose-sparing potential, and durable efficacy following a single dose, strengthen the rationale for developing HK-fbp1 as a versatile whole-cell antifungal platform.

  • Open Access

    Lipid Flippase Mediated Membrane Asymmetry Governs Extracellular Vesicles Biogenesis and Host Interactions in Cryptococcus neoformans

    by Siddhi Pawar, Yu Zhang, Christopher Varsanyi, Varsha Gadiyar, Samantha Avina, Raymond Birge, Chaoyang Xue

    Cryptococcus neoformans is the leading cause of fungal meningitis in immunocompromised patients. Alveolar macrophages are the first line of defense against Cryptococcus infection. Our previous study showed that deletion of Cdc50, the regulatory subunit of P4-ATPase (lipid flippase) complex, results in increased phagocytosis and macrophage killing, and avirulence in animal models. However, how fungal flippase dysfunction modulates Cryptococcus -macrophage interaction remains unknown. Here we identify Cdc50 as a central determinant of membrane lipid homeostasis, extracellular vesicle (EV) biogenesis and macrophage responses in C. neoformans . Our whole cell lipidomic analysis revealed that loss of Cdc50 disrupted membrane lipid homeostasis leading to phospholipid enrichment in cdc50Δ mutant, and a reduction in fatty acid production accompanied by pronounced ultrastructural defects in membrane architecture. Loss of Cdc50 also induced a hyper-vesiculating phenotype, with cdc50Δ producing significantly more extracellular vesicles (EVs) than wild type H99 cells. Lipidomic profiling of cdc50Δ EVs revealed enrichment of phospholipids, including phosphatidylserine (PS), indicating active lipid sorting during vesicle biogenesis. Functional analysis showed that EVs from the wildtype H99 suppress phagocytosis whereas cdc50Δ EVs enhance phagocytosis, indicating a differential macrophage priming. Despite increased PS externalization in cdc50Δ cells and EVs, macrophage recognition and uptake occur independent of PS-mediated efferocytosis pathways, including PS receptor MertK. Following macrophage uptake, cdc50Δ were intrinsically vulnerable to macrophage killing due to rapid phagosome acidification. Together, we demonstrate that Cdc50 dependent lipid homeostasis regulates EV production, lipid composition, membrane architecture and drives the intracellular fate of C. neoformans . IMPORTANCE: Cryptococcus neoformans is the leading cause of fungal meningitis in immunocompromised individuals. Understanding how this pathogen evades host immune mediated clearance is essential for developing new treatment strategies. Here, we demonstrated that Cdc50, the regulatory subunit of fungal lipid flippase complex, regulates membrane lipid homeostasis that governs extracellular vesicles (EV) biogenesis and macrophage immune responses. Loss of Cdc50 drives global membrane lipid remodeling, hyper-production of phospholipid enriched EVs that enhance macrophage phagocytosis, while the wild-type EV reduce macrophage phagocytosis. Contrary to the prevailing assumption that phosphatidylserine (PS) externalization on the fungal surfaces mimics the mammalian “eat-me signal”, we show fungal PS does not engage canonical PS receptor MertK, revealing a fundamental difference between fungal and mammalian PS biology. Furthermore, cdc50 Δ cells are unable to resist phagosomal acidification, rendering them susceptible to macrophage killing. These findings establish how phospholipid homeostasis contributes to early host-pathogen interactions and serves as a compelling antifungal target in cryptococcosis.

  • Open Access

    Mannoprotein Cig1 contributes to the immunogenicity of a heat-killed F-box protein Fbp1 Cryptococcus neoformans vaccine model

    by Samantha L. Avina, Siddhi Pawar, Roshni N. Kadam, Amariliz Rivera, Chaoyang Xue

    Currently, no fungal vaccine exists for clinical use, while fungal infections are responsible for over 1.5 million deaths every year. Our previous studies identified a Cryptococcus neoformans mutant strain fbp1 Δ as a potential vaccine candidate. This strain contains deletion of the F-box protein Fbp1, a key subunit of the SCF E3 ligase complex necessary for ubiquitin-mediated proteolysis. Vaccination with heat-killed fbp1 Δ (HK- fbp1 ) can elicit an interferon gamma (IFN-γ)-dependent Type 1 immune response and provide protection against C. neoformans and its sibling species C. gattii . However, we have yet to decipher the immunogenic factor(s) expressed by the fbp1 ∆ mutant that are responsible for the induction of the protective immune response. In this study, we have identified that the capsule plays an important role in HK- fbp1 vaccine-mediated protection as acapsular HK- fbp1 cells showed diminished protection against wild-type challenge. Additionally, our studies have shown that Cytokine Inducing Glycoprotein 1 (Cig1), a GPI-anchored mannoprotein, is regulated by Fbp1 and contributes to the immunogenicity of HK- fbp1 . Deletion of Cig1 in the fbp1 Δ background resulted in decreased recruitment of antifungal effector T cells and diminished production of protective inflammatory cytokines by the host. Furthermore, loss of Cig1 in the fbp1 Δ mutant resulted in reduced protection in vaccination survival studies at lower vaccine inoculum doses compared to HK- fbp1 . In aggregate, these findings demonstrate Cig1 is an antigen contributing to the immunogenicity of HK- fbp1 that may be utilized to further optimize the HK- fbp1 fungal vaccine as a tool in the arsenal against invasive fungal infections.


  • Open Access

    Mannoprotein Cig1 Contributes to the Immunogenicity of a Heat-Killed F-box Protein Fbp1 Cryptococcus neoformans Vaccine Model

    by Samantha Avina, Siddhi Pawar, Amariliz Rivera, Chaoyang Xue

    Currently, no fungal vaccine exists for clinical use while fungal infections are responsible for over 1.5 million deaths every year. Our previous studies identified a Cryptococcus neoformans mutant strain fbp1 Δ as a potential vaccine candidate. This mutant strain contains a deletion of the F-box protein Fbp1, a key subunit of the SCF E3 ligase complex necessary for ubiquitin-mediated proteolysis. Vaccination with heat-killed fbp1 Δ (HK- fbp1) can elicit protection against C. neoformans parental strain and its sibling species C. gattii in an interferon gamma (IFN-γ) dependent Type 1 immune response. However, we have yet to decipher the immunogenic factor(s) expressed by the fbp1 Δ mutant that are responsible for the induction of the protective immune response. In this study, we have identified that capsule plays an important role in HK- fbp1 vaccine mediated protection, as acapsular HK- fbp1 cells showed diminished protection against wild type challenge. Additionally, our studies have shown that Cytokine Inducing Glycoprotein 1 (Cig1), a GPI anchored mannoprotein, is regulated by Fbp1 and contributes to the immunogenicity of HK- fbp1 . Deletion of Cig1 in the fbp1 Δ background resulted in decreased recruitment of anti-fungal effector T cells and diminished production of protective inflammatory cytokines by the host. Furthermore, loss of Cig1 in the fbp1 Δ mutant resulted in reduced protection in vaccination survival studies at lower vaccine inoculum doses compared to HK- fbp1 . In aggregate, these findings demonstrate Cig1 is an antigen contributing to the immunogenicity of HK- fbp1 that may be utilized to further optimize the HK- fbp1 fungal vaccine as a tool in the arsenal against invasive fungal infections.

  • Open Access

    Cryptococcosis, tuberculosis, and a kidney cancer fail to fit the atherosclerosis paradigm for foam cell lipid content

    by Valentina Guerrini, Brendan Prideaux, Rehan Khan, Selvakumar Subbian, Yina Wang, Evita Sadimin, Siddhi Pawar, Rahul Ukey, Eric A. Singer, Chaoyang Xue, et al.

    Foam cells are dysfunctional, lipid-laden macrophages associated with chronic inflammation of diverse origin. The long-standing paradigm that foam cells are cholesterol-laden derives from atherosclerosis research. We previously showed that, in tuberculosis, foam cells surprisingly accumulate triglycerides. Here, we utilized bacterial ( Mycobacterium tuberculosis ), fungal ( Cryptococcus neoformans ), and human papillary renal cell carcinoma (pRCC) models to address the need for a new explanation of foam cell biogenesis. We applied mass spectrometry-based imaging to assess the spatial distribution of storage lipids relative to foam-cell-rich areas in lesional tissues, and we characterized lipid-laden macrophages generated under corresponding in vitro conditions. The in vivo data and the in vitro findings showed that cryptococcus-infected macrophages accumulate triglycerides, while macrophages exposed to pRCC- conditioned-medium accumulated both triglycerides and cholesterol. Moreover, cryptococcus- and mycobacterium-infected macrophages accumulated triglycerides in different ways. Collectively, the data show that the molecular events underlying foam cell formation are specific to disease and microenvironment. Since foam cells are potential therapeutic targets, recognizing that their formation is disease-specific opens new biomedical research directions.